iCAD, Inc. To Participate At Two Investor Conferences In May

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that Company management will participate in two upcoming investor conferences.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC